1. Get the Diabetes Forum App for your phone - available on iOS and Android.
    Dismiss Notice
  2. Guest, we'd love to know what you think about the forum! Take the Diabetes Forum Survey 2021 »
    Dismiss Notice
  3. Diabetes Forum should not be used in an emergency and does not replace your healthcare professional relationship. Posts can be seen by the public.
    Dismiss Notice
  4. Guest, stay home, stay safe, save the NHS. Stay up to date with information about keeping yourself and people around you safe here and GOV.UK: Coronavirus (COVID-19). Think you have symptoms? NHS 111 service is available here.
    Dismiss Notice
Dismiss Notice
Find support, ask questions and share your experiences. Join the community »

NHS cost cutting could harm type 2 diabetes self-management

Discussion in 'Diabetes News' started by DCUK NewsBot, Apr 9, 2015.

  1. DCUK NewsBot

    DCUK NewsBot · Well-Known Member

    Likes Received:
    Trophy Points:
    A cost cutting measure in Tower Hamlets, London is being used as an example of how the NHS could save as much as £20 million, or more, if it clamps down on restrictions of blood glucose testing supplies for people with type 2 diabetes. Whilst such a strategy would doubtless save money in the short term, it is one that could well lead to dis-empowerment for people with type 2 diabetes that are actively interested in improving their health and could add significantly to the risks of both short and long term diabetes complications. The results of the cost cutting intervention were published online on 1 April by the British Journal of General Practice. The intervention involved greatly restricting prescriptions of blood glucose testing to people with type 2 diabetes that were not on insulin. Strict restriction of blood testing supplies The study period took place between 2010 and 2013 and involved a total of 35,635 patients with type 2 diabetes and not treated with insulin. Of these, 19,602 were under the care of two Clinical Commissioning Groups (CCG) that imposed strict restriction of self-monitoring supplies and the 16,033 patients were under the care of a CCG that did not impose much stricter restriction of testing supplies. The study saw use of blood testing supplies reduced from 29.6% to 6.0% within the CCGs that put the cost cutting intervention in place. Within the CCG that did not apply the intervention, use of self-testing supplies fell from 47.1% o 38.7% over the same period. The study reports that the impact on cost was a 4.9% reduction in the cost of self-testing supplies in the intervention group, compared with an increase of 5.0% within the non-intervention group. The study includes a note that the cost of prescribing of diabetes self-monitoring supplies increased by £19.4 million between 2009 and 2012. No review of the impact on health Whilst the study looked at cost savings, it did not review the impact on health of the people with type 2 diabetes that were involved within the study. Self-monitoring of blood glucose can play an important role within the lives of people with non-insulin treated type 2 diabetes. People on certain tablets for type 2 diabetes, such as sulphonylureas or prandial glucose regulators, face a risk of suffering severe hypoglycemia which is made more difficult to identify, manage and prevent without the use of blood glucose testing. Self-monitoring of blood glucose also enables people with type 2 diabetes to make informed changes to their lifestyle in order to improve their blood glucose control and reduce the risks of serious long term complications such as kidney disease and foot amputation. In those that are committed to learning from self-testing, monitoring of blood glucose can also act as a strong motivational tool. In 2014, Diabetes.co.uk responded to concerns from people with type 2 diabetes that were facing test strip restrictions by launching the Type2Testing program. The program not only provided blood glucose testing supplies at a cheaper rate than pharmacies but also included instruction on how users can make the most of blood glucose testing to improve their long term blood glucose control. The Type2Testing program has seen the average HbA1c, of those that have taken part, drop from an average of 7.6% at the start of the program to 6.7% six months later.

    Continue reading...
  2. hilte

    hilte · Newbie

    Likes Received:
    Trophy Points:
    At the end of last year I received a letter, I fell into the category of those patients that the GP Practice felt was no longer able to provide prescriptions for re - self testing via use of test strips and associated needles. I was shocked . Most of all it had really helped me keep my blue sugar under control. This has caused me to have a "dent " in my confidence - I was and remain deeply saddened. The negative impact on me is far greater than the negative impact on cost .When newly diagnosed I was so thankful and appreciative for them- an observation , one of the non UK producers of the glucose needle tester spoke to me following a call to their helpline - stating that he was surprised in England how infrequent was the daily testing .He provided me with additional testing information which helped me understand which foods and when impacted on me.

    It is my understanding that for a short term budget saving by one group , will generate a bigger long term cost .How sad that there is an erosion in professional caring .

    I personally suggest that everyone who is provided their test strips etc via prescription should personally thank their doctors and use them responsibly.
  • Meet the Community

    Find support, connect with others, ask questions and share your experiences with people with diabetes, their carers and family.

    Did you know: 7 out of 10 people improve their understanding of diabetes within 6 months of being a Diabetes Forum member. Get the Diabetes Forum App and stay connected on iOS and Android

    Grab the app!
  • Tweet with us

  • Like us on Facebook